Skip to content

Telemedicine in Kidney Disease Study

An interventional prospective cohort study with matched control group to compare a telemedicine model of care for prevalent renal transplant recipients and Chronic Kidney Disease patients with standard medical care to assess the feasibility of a telemedicine model of care

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614001237673
Acronym
TIKED
Enrollment
62
Registered
2014-11-26
Start date
2015-05-19
Completion date
2016-06-07
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To compare the current model of care for Transplant recipients and Chronic Kidney disease patients, which is face to face consultation with specialist Kidney Doctor with a new model of care which will consist of up to 75 % of these visits done from patients home or nearby telehealth facility. We are expecting that conducting some medical consultations by telemedicine will be feasible and non-inferior to standard model of care and the patients will be happy with this new model of care

Interventions

Patients who meet the inclusion criteria will be offered to have up to 75% of their clinic appointments by telemedicine. The study intervention will be the use of intermittent telemedicine consultations to the patient in their own home (using the QLD Health approved Cisco Jabber Program) or at a nearby health facility (Gympie, Caloundra, Maleny), combined with some face to face consultations (at Nambour Hospital). The frequency of telemedicine consultations will be as deemed suitable by the med

Patients who meet the inclusion criteria will be offered to have up to 75% of their clinic appointments by telemedicine. The study intervention will be the use of intermittent telemedicine consultations to the patient in their own home (using the QLD Health approved Cisco Jabber Program) or at a nearby health facility (Gympie, Caloundra, Maleny), combined with some face to face consultations (at Nambour Hospital). The frequency of telemedicine consultations will be as deemed suitable by the medical staff but will not exceed 75% of consultations. The Duration of intervention will be 24 months.

Sponsors

Associate Professor Nicholas Andrew Gray, Director of Renal Services at SCHHS - Nambour General Hospital
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1.Age >=18 years and able to give informed consent 2.Patient living at least 15km from the specialist clinic or in an aged care facility 3.Deemed suitable for telemedicine care as determined by the medical team 4.Must be a patient attending the Sunshine Coast Hospital and Health Service, renal service with a functioning renal transplant or a diagnosis of Chronic Kidney Disease.

Exclusion criteria

1.Poor compliance as determined by medical staff 2.Cognitive impairment 3.Life expectancy (<1 year) 4.Interpreter required 5.Inability to access (or use) a computer with webcam and “Cisco Jabber” software, or inability to attend a local health centre with telemedicine available 6.Unable to measure blood pressure prior to the appointment (at home, chemist, GP, local health centre, other) 7.Unable to weigh at home or the health centre that has a telemedicine clinic 8.Unable to perform pathology prior to the appointment 9.Participation in another research study 10.Pregnant

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026